1. Home
  2. TWST vs AXSM Comparison

TWST vs AXSM Comparison

Compare TWST & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$110.22

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

SELL

Current Price

$135.54

Market Cap

7.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
TWST
AXSM
Founded
2013
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
7.5B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
TWST
AXSM
Price
$110.22
$135.54
Analyst Decision
Buy
Strong Buy
Analyst Count
13
22
Target Price
$128.92
★ $264.62
AVG Volume (30 Days)
★ 2.3M
1.0M
Earning Date
11-12-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 38.56
EPS
★ N/A
N/A
Revenue
★ $459,433,000.00
N/A
Revenue This Year
$21.02
$49.25
Revenue Next Year
$18.75
$52.08
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 22.00
N/A
52 Week Low
$25.23
$123.00
52 Week High
$219.71
$260.19

Technical Indicators

Market Signals
Indicator
TWST
AXSM
Relative Strength Index (RSI) 38.28 36.03
Support Level $79.90 $123.00
Resistance Level $155.44 $225.16
Average True Range (ATR) 15.07 7.85
MACD -3.22 1.71
Stochastic Oscillator 18.52 42.78

Price Performance

Historical Comparison
TWST
AXSM

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: